| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/02/1995 | EP0664813A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 08/02/1995 | EP0664712A1 High potency vaccines |
| 08/02/1995 | EP0664710A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF |
| 08/02/1995 | EP0522030B1 Hepatitis b vaccine |
| 08/02/1995 | CN1106021A Method for the separation of bacterial lipopolysaccharides from protein-containing solutions |
| 08/02/1995 | CN1105883A Lactobacillus used to enhance immunological functions |
| 08/01/1995 | US5438120 Purified Bordetella pertussius antigen used in vaccine against whooping cough; side effect reduction |
| 08/01/1995 | US5437974 DNA sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
| 08/01/1995 | US5437951 A genetic construct comprising a PAPILLOMAVIRUS L1 gene; vaccines, diagnostic kits; genetic engineering |
| 08/01/1995 | US5437865 Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium |
| 08/01/1995 | US5437864 Removing blood from patient, administering a monoclonal antibody to neutralization |
| 08/01/1995 | CA2141392A1 Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same |
| 08/01/1995 | CA1336529C Synthetic peptide antigens for the detection of htlv-1 infection |
| 08/01/1995 | CA1336508C Method of immobilizing physiologically active substances |
| 08/01/1995 | CA1336497C Immunoconjugates for cancer diagnosis and therapy |
| 08/01/1995 | CA1336496C Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
| 07/28/1995 | CA2141277A1 Method for preparing thioether conjugates |
| 07/27/1995 | WO1995020162A1 Peptomers with enhanced immunogenicity |
| 07/27/1995 | WO1995020049A1 Herpesvirus pre-(viral dna replication) enveloped |
| 07/27/1995 | WO1995020048A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms |
| 07/27/1995 | WO1995020045A1 Antibodies to egf receptor and their antitumour effect |
| 07/27/1995 | WO1995019985A1 Haemopoietic maturation factor |
| 07/27/1995 | WO1995019790A1 Humanized antibodies against leukocyte adhesion molecule vla-4 |
| 07/27/1995 | WO1995019788A1 Inhibitors and target molecule co-localization |
| 07/27/1995 | WO1995019783A1 Induction of anti-tumor cytotoxic t lymphocytes in humans using synthetic peptide epitopes |
| 07/27/1995 | WO1995019777A2 Use of diesters of muramyl peptides in oral form as immunostimulating agents |
| 07/27/1995 | WO1995017511A3 Mycobacteria virulence factors and a method for their identification |
| 07/27/1995 | WO1995014778A3 Dna sequence coding for a bmp receptor |
| 07/27/1995 | WO1995012677A3 Immunodominant human t-cell epitopes of hepatitis c virus |
| 07/27/1995 | WO1995011975A3 Retroviral superantigens, superantigen peptides, and methods of use |
| 07/27/1995 | CA2181920A1 Induction of anti-tumor cytotoxic t lymphocytes in humans using synthetic peptide epitopes |
| 07/27/1995 | CA2181899A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents |
| 07/27/1995 | CA2181431A1 Haemopoietic maturation factor |
| 07/27/1995 | CA2180834A1 Antibodies to egf receptor and their antitumour effect |
| 07/27/1995 | CA2157015A1 Inhibitors and target molecule co-localization |
| 07/27/1995 | CA2126361A1 Gene encoding cationic amino acid transporter protein |
| 07/26/1995 | EP0664337A1 Methods for utilizing cell lines which lack human class II histocompatibility antigens |
| 07/26/1995 | EP0663916A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 07/26/1995 | EP0663826A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
| 07/26/1995 | EP0167616B1 Cytokeratin tumor markers and assays for their detection |
| 07/25/1995 | US5436321 Antibodies to the lipopolysaccharide bonding opsonin septin |
| 07/25/1995 | US5436320 Antibody reagents that identify the carboxy-terminal peptide of the GTP-binding protein Go |
| 07/25/1995 | US5436319 Lymphocytes for immunoassay |
| 07/25/1995 | US5436318 Hepatitis C virus epitopes |
| 07/25/1995 | US5436157 Human intra-acrosomal sperm antigen |
| 07/25/1995 | US5436155 Isolated DNA encoding a somatostatin receptor |
| 07/25/1995 | US5436154 Stable hybridoma cells and antigen-antibodies |
| 07/25/1995 | US5436139 Non-passageable virus |
| 07/25/1995 | US5436127 Epitope-related peptides of human parvovirus |
| 07/25/1995 | US5436126 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines |
| 07/25/1995 | US5436005 Low virulence infectiouns laryngotracheitis (ILT) virus for vaccinating birds |
| 07/25/1995 | US5436000 Flagella-less borrelia |
| 07/25/1995 | US5435990 Chelate-antibody complexes, treatment and diagnosis of cancer, tetraazacyclododecane compounds |
| 07/25/1995 | CA1336473C Synthetic peptide antigens for the detection of hiv-1 infection |
| 07/25/1995 | CA1336408C Treponema hyodysenteriae antigen and uses therefor |
| 07/25/1995 | CA1336407C Prevention and treatment of retroviral disease |
| 07/25/1995 | CA1336406C Bovine vaccine composition and method for preventing trichomas infection using same |
| 07/21/1995 | CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use |
| 07/20/1995 | WO1995019438A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 07/20/1995 | WO1995019435A2 T cell antigen receptor v region proteins and methods of preparation thereof |
| 07/20/1995 | WO1995019429A2 Method and reagent for inhibiting hepatitis c virus replication |
| 07/20/1995 | WO1995019375A1 Peptides and methods against psoriasis |
| 07/20/1995 | WO1995019371A2 Expression of surface layer proteins |
| 07/20/1995 | WO1995019181A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS |
| 07/20/1995 | DE19500723A1 New variable domains of antibody recognising cancer specific mucin |
| 07/20/1995 | CA2181171A1 T cell antigen receptor v region proteins and methods of preparation thereof |
| 07/20/1995 | CA2181159A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 07/20/1995 | CA2180740A1 Method and reagent for inhibiting hepatitis c virus replication |
| 07/20/1995 | CA2179280A1 Peptides and methods against psoriasis |
| 07/19/1995 | EP0663404A1 Antibodies for the detection of Salmonella |
| 07/19/1995 | EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 07/19/1995 | EP0663008A1 Improvements in or relating to immune response modification |
| 07/19/1995 | EP0663007A1 Trophic factor having ion channel-inducing activity in neuronal cells |
| 07/19/1995 | EP0662976A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/19/1995 | EP0662842A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 07/19/1995 | EP0662839A1 Vaccines and antigenic conjugates |
| 07/19/1995 | EP0662838A1 Method of treating rheumatoid arthritis with type ii collagen |
| 07/19/1995 | EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/19/1995 | EP0662782A1 Pp14-based therapy |
| 07/19/1995 | EP0527760B1 Methods and compositions for vaccination against hiv |
| 07/19/1995 | EP0424416B1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex |
| 07/19/1995 | EP0332677B1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 07/19/1995 | CN1105270A Product containing secretion-type immunoglobulin A and preparing process thereof |
| 07/18/1995 | US5434287 Bifunctional DTPA-type ligand |
| 07/18/1995 | US5434253 DNA encoding Helicobacter pylori recombinase |
| 07/18/1995 | US5434131 Chimeric CTLA4 receptor and methods for its use |
| 07/18/1995 | US5434077 Borrelia burgdorferi strain 257 |
| 07/18/1995 | US5433948 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 07/18/1995 | US5433945 Immunoprotective genetically-detoxified mutants of pertussis toxin |
| 07/18/1995 | CA1336322C Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors |
| 07/13/1995 | WO1995018861A1 Influenza vaccine |
| 07/13/1995 | WO1995018860A1 Control of marek's disease by the inhibition of latency and tumor cell development |
| 07/13/1995 | WO1995018852A1 Herpesvirus replication defective mutants |
| 07/13/1995 | WO1995018832A1 New polyaminocarboxylate chelators |
| 07/13/1995 | WO1995018826A2 Purified primate ctla-8 antigens and related reagents |
| 07/13/1995 | WO1995018819A1 Ligand that binds fas antigen |
| 07/13/1995 | WO1995018634A1 Human monoclonal antibodies to herpes simplex virus and methods therefor |
| 07/13/1995 | WO1995018633A1 Soft agar penetration-defective mutants |
| 07/13/1995 | WO1995018632A1 Nucleotide and amino acid sequences of a t. pallidum rare outer membrane protein |
| 07/13/1995 | WO1995018631A1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |